Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP).
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Ronaghy, A; Streilein, RD; Hall, RP
Published Date
- April 2014
Published In
Volume / Issue
- 74 / 1
Start / End Page
- 93 - 94
PubMed ID
- 24461673
Electronic International Standard Serial Number (EISSN)
- 1873-569X
Digital Object Identifier (DOI)
- 10.1016/j.jdermsci.2013.11.014
Language
- eng
Conference Location
- Netherlands